Can COVID-19 herd immunity be achieved at a city level?
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0299574 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yuval Arbel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sir Harry Solomon School of Economics and Management, Western Galilee College, Acre, Israel. Hauptthemen laut MEDLINE: Immunity, Herd, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We propose a new approach to estimate the vaccination rates required to achieve herd immunity against SARS-COV2 virus at a city level. Based on information obtained from the Israeli Ministry of Health, we estimate two separate quadratic models, one for each dose of the BNT162b2 mRNA Pfizer vaccine. The dependent variable is the scope of morbidity, expressed as the number of cases per 10,000 persons. The independent variables are the first and second vaccination rates and their squares. The outcomes corroborate that herd immunity is achieved in the case that 71 percent of the urban population is vaccinated, and the minimum anticipated scope of morbidity is approximately 5 active COVID-19 cases per 10,000 persons, compared to 53–67 cases per 10,000 persons for zero vaccination rate. Findings emphasize the importance of vaccinations and demonstrate that urban herd immunity may be defined as a situation in which people continue to interact, yet the COVID-19 spread is contained. This, in turn, might prevent the need for lockdowns or other limitations at the city level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sir Harry Solomon School of Economics and Management, Western Galilee College, Acre, Israel.
- Department of Mathematics, Bar Ilan University, Ramat Gan, Israel.
- Faculty of Social Sciences, Banking and Finance Program, Bar Ilan University, Ramat Gan, Israel.
- The Ruth and Bruce Rapoport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
- Department of Dermatology, Emek Medical Center, Afula, Israel.
ORCID-Profile: Yuval Arbel
Zitieren
APA
Arbel, Y., Arbel, Y., Kerner, A., & Kerner, M. (2024). Can COVID-19 herd immunity be achieved at a city level?. PLOS ONE. https://doi.org/10.1371/journal.pone.0299574
Vancouver
Arbel Y, Arbel Y, Kerner A, Kerner M. Can COVID-19 herd immunity be achieved at a city level?. PLOS ONE. 2024. doi:10.1371/journal.pone.0299574
BibTeX
@article{Arbel2024,
author = {Arbel, Yuval and Arbel, Yifat and Kerner, Amichai and Kerner, Miryam},
title = {Can COVID-19 herd immunity be achieved at a city level?},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0299574}
}
EUVIMED